Open this publication in new window or tab >>Show others...
2010 (English)In: International Journal of Angiology, ISSN 0392-9590, E-ISSN 1827-1839, Vol. 29, no 4, p. 331-337Article in journal (Refereed) Published
Abstract [en]
AIM:
The aim of the present pilot study was to relate the activity of MAPK p38 with the levels of pro- and anti-inflammatory cytokines in a small cohort of patients with either stable angina (N=5) or intermittent claudication (N=5) compared to healthy controls (N=10).
METHODS:
The activity of MAPK p38 was determined in peripheral blood mononuclear cells, isolated from whole blood by western blot using phospho-specific anti-MAPK p38 antibodies. Cytokine levels of 11 pro- and anti-inflammatory cytokines were determined from the serum using flow cytometry.
RESULTS:
We found a significant elevation of the MAPK p38 activity in the intermittent claudication group (P=0.0027) compared with the healthy control group whereas the stable angina group showed similar MAPK p38 activity as the healthy control group. The IL-10 level in serum found in the stable angina group was significantly higher compared with both the healthy control group (P=0.0116) and the intermittent claudication group (P=0.0317).
CONCLUSION:
Our results imply that there is a casual relationship between increased levels of the anti-inflammatory cytokines IL-10 and IL-4 and the activity of the MAPK p38. Possibly has IL-10 a protective role that down-regulates the activity of MAPK p38 and thereby further inflammatory processes in stable angina patients.
Place, publisher, year, edition, pages
Torino: Minerva Medica, 2010
Keywords
p38 mitogen-activated protein kinases, Interleukin-10, Intermittent claudication
National Category
Medical and Health Sciences Cardiology and Cardiovascular Disease
Research subject
Cardiology
Identifiers
urn:nbn:se:oru:diva-12845 (URN)000283516700007 ()20671651 (PubMedID)
2011-01-102011-01-032025-02-10Bibliographically approved